Eveglim-M 2 Tablet SR
Eveglim-M 2 Tablet SR
Glimepiride (2mg) + Metformin (500mg)
Y Glim M 2mg/500mg Tablet SR
VHVL Inc
Glimepiride 2mg
Pack Size
1 units
Price
Save ₹8
that's 22% off!
About This Medicine
Product description & overview
Eveglim-M 2 Tablet SR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 500mg, designed for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, works by stimulating pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, improves insulin sensitivity and decreases hepatic glucose production, contributing to better glycemic control. The sustained-release (SR) formulation ensures a gradual release of the active ingredients, promoting stable blood sugar levels throughout the day and enhancing patient compliance by reducing dosing frequency. Eveglim-M 2 Tablet SR is typically prescribed when diet, exercise, and monotherapy with either agent alone do not achieve adequate glycemic control. It is important to use this medication under medical supervision, as improper use may lead to hypoglycemia or gastrointestinal side effects such as nausea, diarrhea, or abdominal discomfort. Regular monitoring of blood glucose and renal function is recommended during treatment. This combination therapy offers a synergistic approach to managing type 2 diabetes, helping patients maintain optimal blood sugar levels and reduce the risk of diabetes-related complications.
Active composition
Glimepiride 2 mg
+1 more active ingredient
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride: Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin: Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Eveglim-M 2 Tablet SR.
High Risk
Pregnancy
Eveglim-M 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Eveglim-M 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Eveglim-M 2 Tablet SR may be needed. Please consult your doctor. Eveglim-M 2 Tablet SR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Eveglim-M 2 Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Eveglim-M 2 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Eveglim-M 2 Tablet SR may be needed. Please consult your doctor. Use of Eveglim-M 2 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Eveglim-M 2 Tablet SR
Products matching your search
Glimicer 1mg Tablet
Glimicer 1mg Tablet
Glyciphage-PG 1 Tablet SR
Glyciphage-PG 1 Tablet SR
Glimser Forte 1 Tablet PR
Glimser Forte 1 Tablet PR
Justmet Safe 2 Tablet ER
Justmet Safe 2 Tablet ER
Glucut 2 MT Tablet
Glucut 2 MT Tablet
WE-Sita M Tablet
WE-Sita M Tablet
WE-Sita 50 Tablet
WE-Sita 50 Tablet
Glized-M Tablet PR